HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Plunkett Selected Research

triphosphoric acid (triphosphate)

3/2008Phase I trial of nelarabine in indolent leukemias.
11/2004Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
10/2004Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
2/2004Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
12/2003Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
10/2002Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Plunkett Research Topics

Disease

32Neoplasms (Cancer)
01/2021 - 01/2002
30B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 02/2002
23Leukemia
01/2021 - 02/2002
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 02/2002
8Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 12/2003
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2012 - 10/2003
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2014 - 10/2003
6Ataxia Telangiectasia (Louis Bar Syndrome)
08/2011 - 08/2006
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 06/2005
4Chromosome Aberrations (Chromosome Abnormalities)
12/2019 - 08/2005
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2014 - 10/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 10/2005
2Lung Neoplasms (Lung Cancer)
11/2017 - 01/2017
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2016 - 08/2010
2Residual Neoplasm
01/2016 - 03/2011
2Adenocarcinoma
04/2014 - 09/2003
2Blast Crisis (Blast Phase)
08/2012 - 02/2005
2Lymphoma (Lymphomas)
06/2005 - 01/2002
1Neoplasm Metastasis (Metastasis)
11/2019
1Inflammation (Inflammations)
11/2019
1Metaplasia
11/2019
1Obesity
11/2019
1Pancreatic Cyst
11/2019
1Carcinogenesis
11/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Exanthema (Rash)
11/2017
1Hyperbilirubinemia
11/2017
1Hypersensitivity (Allergy)
11/2017
1Disease Progression
02/2015
1Hematologic Diseases (Blood Diseases)
02/2015
1Diarrhea
06/2014
1Genetic Translocation (Chromosomal Translocation)
04/2014

Drug/Important Bio-Agent (IBA)

17fludarabineIBA
12/2021 - 01/2002
16Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018 - 10/2002
15Clofarabine (Clolar)FDA Link
01/2018 - 03/2003
14NucleosidesIBA
01/2019 - 09/2002
13DNA (Deoxyribonucleic Acid)IBA
12/2019 - 01/2002
92'- cyano- 2'- deoxyarabinofuranosylcytosineIBA
12/2019 - 08/2005
8GemcitabineFDA Link
11/2014 - 02/2002
7Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2005
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 02/2002
6Rituximab (Mabthera)FDA Link
12/2021 - 06/2005
6ProdrugsIBA
01/2018 - 02/2002
6sapacitabineIBA
01/2018 - 01/2010
6triphosphoric acid (triphosphate)IBA
03/2008 - 10/2002
5Pharmaceutical PreparationsIBA
12/2019 - 09/2003
5Antineoplastic Agents (Antineoplastics)IBA
02/2010 - 05/2003
4MicroRNAs (MicroRNA)IBA
12/2016 - 10/2007
4Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2013 - 12/2006
47-hydroxystaurosporine (UCN 01)IBA
05/2007 - 02/2002
3venetoclaxIBA
01/2022 - 01/2019
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022 - 05/2009
3ibrutinibIBA
12/2021 - 01/2019
3Biological ProductsIBA
01/2019 - 08/2010
3Arabinofuranosylcytosine TriphosphateIBA
01/2018 - 10/2002
3Messenger RNA (mRNA)IBA
09/2013 - 10/2005
3DNA-Activated Protein KinaseIBA
08/2011 - 01/2008
3N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
08/2010 - 05/2009
3CladribineFDA LinkGeneric
07/2006 - 10/2002
2Apoptosis Regulatory ProteinsIBA
01/2022 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2008
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2019 - 12/2016
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2018 - 11/2017
2Purine NucleosidesIBA
01/2018 - 11/2017
2Transaminases (Aminotransferases)IBA
11/2017 - 06/2014
2Ligases (Synthetase)IBA
01/2016 - 04/2009
2alvocidib (flavopiridol)IBA
02/2015 - 10/2005
2bcr-abl Fusion ProteinsIBA
04/2014 - 11/2006
2HomoharringtonineIBA
04/2014 - 01/2011
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
09/2013 - 12/2003
2DeoxycytidineIBA
08/2012 - 01/2010
2NK314IBA
08/2011 - 05/2007
2ChromatinIBA
12/2010 - 01/2008
2NucleotidesIBA
06/2009 - 05/2008
2rabacfosadineIBA
06/2009 - 05/2008
2nelarabine (506U78)FDA Link
03/2008 - 11/2006
2Alkylating AgentsIBA
09/2007 - 02/2002
2Mitochondrial DNA (mtDNA)IBA
12/2006 - 09/2003
2Free RadicalsIBA
09/2003 - 05/2003
1RNA Polymerase II (RNA Polymerase B)IBA
01/2022
1CYC065IBA
01/2022
1obinutuzumabIBA
12/2021
114- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
01/2021
1TrabectedinIBA
12/2019
1fibroblast growth factor 21IBA
11/2019
1Triglycerides (Triacylglycerol)IBA
11/2019
1Drug CombinationsIBA
01/2018
1Platinum Compounds (Compounds, Platinum)IBA
01/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1Taxoids (Taxanes)IBA
01/2018
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2017
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1Arginine (L-Arginine)FDA Link
06/2015
1Cyclin-Dependent Kinase 9IBA
02/2015

Therapy/Procedure

19Therapeutics
08/2021 - 02/2002
7Drug Therapy (Chemotherapy)
01/2017 - 06/2005
2Intravenous Infusions
02/2005 - 12/2003
1Immunomodulation
12/2019
1Injections
11/2019